Pathogenic Substantiation of Application of Erythropoietin Modified Forms and Peptide Analogues as Cytotprotectors
Pharmacy Formulas
doi 10.17816/phf21382
Full Text
Open PDFAbstract
Available in full text
Date
March 28, 2020
Authors
Publisher
ECO-Vector LLC